Sutro Biopharma Inc
NASDAQ:STRO
Sutro Biopharma Inc
NASDAQ:STRO
Price:
3.85 USD
3.77%
Market Closed
Updated:
Jun 11, 2024
Sutro Biopharma Inc
Depreciation & Amortization
|
Sutro Biopharma Inc
Depreciation & Amortization Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sutro Biopharma Inc
NASDAQ:STRO
|
Depreciation & Amortization
$7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Depreciation & Amortization
$8.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
37%
|
CAGR 10-Years
26%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Depreciation & Amortization
$2.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
14%
|
CAGR 10-Years
18%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Depreciation & Amortization
$4.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
12%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Depreciation & Amortization
$196m
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
14%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Depreciation & Amortization
$435.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
26%
|
See Also
What is Sutro Biopharma Inc's Depreciation & Amortization?
Depreciation & Amortization
7m
USD
7m
USD
Based on the financial report for Mar 31, 2024, Sutro Biopharma Inc's Depreciation & Amortization amounts to 7m USD.
What is Sutro Biopharma Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
9%
9%
Over the last year, the Depreciation & Amortization growth was 16%. The average annual Depreciation & Amortization growth rates for Sutro Biopharma Inc have been 16% over the past three years , 9% over the past five years .
You don't have any saved screeners yet
